EVALUASI PENGGUNAAN OBAT KEMOTERAPI
PADA PASIEN KANKER SERVIKS
DI RAWAT INAP RSUD DR. MOEWARDI SURAKARTA
TAHUN 2019
Total View This Week0
Total View This Week0
Institusion
Sekolah Tinggi Ilmu Kesehatan Nasional
Author
Hengky, Dwiono
Subject
RN Pharmacy and Pharmaceutical Mathematics
Datestamp
2021-03-02 03:53:10
Abstract :
Cervical cancer is one of the leading causes of death of women associated with cancer. This study aims to determine the description of the use of chemotherapy drugs and evaluate their use in cervical cancer patients in the Hospital Dr. Moewardi in 2019.This research is a non-experimental research with descriptive research design. The sampling technique is purposive sampling where populations that meet the inclusion criteria are taken as samples. Data was collected retrospectively based on medical records of cervical cancer patients. The population of cervical cancer patients in 2019 was 218 patients. The study sample according to the Slovin formula was 69 and 84 patients met the inclusion criteria.The results showed that the age range of 50-59 years had the most cervical cancer in 34 patients (40.48%) with an average of 36 patients in stage IIIB (42.86%). Variations of chemotherapy that are often used are the combination of Paclitaxel and Caboplatin, which is 53 patients (64.29%). Evaluation of the use of chemotherapy drugs results obtained 100% right patient and right drug. Moderate dose accuracy also reaches 100% at the right dose.
Cervical cancer is one of the leading causes of death of women associated with cancer. This study aims to determine the description of the use of chemotherapy drugs and evaluate their use in cervical cancer patients in the Hospital Dr. Moewardi in 2019.This research is a non-experimental research with descriptive research design. The sampling technique is purposive sampling where populations that meet the inclusion criteria are taken as samples. Data was collected retrospectively based on medical records of cervical cancer patients. The population of cervical cancer patients in 2019 was 218 patients. The study sample according to the Slovin formula was 69 and 84 patients met the inclusion criteria.The results showed that the age range of 50-59 years had the most cervical cancer in 34 patients (40.48%) with an average of 36 patients in stage IIIB (42.86%). Variations of chemotherapy that are often used are the combination of Paclitaxel and Caboplatin, which is 53 patients (64.29%). Evaluation of the use of chemotherapy drugs results obtained 100% right patient and right drug. Moderate dose accuracy also reaches 100% at the right dose.
Download
book
BibTex
Latex, Jabref
cloud_download
Original Resource
url resource Institution
